- Home
- OBT vs ITOS Comparison
OBT vs ITOS Comparison
Compare OBT & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBT
- ITOS
- Stock Information
- Founded
- OBT 1892
- ITOS 2011
- Country
- OBT United States
- ITOS United States
- Employees
- OBT N/A
- ITOS N/A
- Industry
- OBT Major Banks
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OBT Finance
- ITOS Health Care
- Exchange
- OBT Nasdaq
- ITOS Nasdaq
- Market Cap
- OBT 267.9M
- ITOS 270.7M
- IPO Year
- OBT N/A
- ITOS 2020
- Fundamental
- Price
- OBT $23.53
- ITOS $6.51
- Analyst Decision
- OBT Buy
- ITOS Strong Buy
- Analyst Count
- OBT 1
- ITOS 3
- Target Price
- OBT $35.50
- ITOS $26.00
- AVG Volume (30 Days)
- OBT 17.9K
- ITOS 413.2K
- Earning Date
- OBT 04-30-2025
- ITOS 05-09-2025
- Dividend Yield
- OBT 2.08%
- ITOS N/A
- EPS Growth
- OBT N/A
- ITOS N/A
- EPS
- OBT 2.47
- ITOS N/A
- Revenue
- OBT $100,028,000.00
- ITOS $35,000,000.00
- Revenue This Year
- OBT $12.69
- ITOS N/A
- Revenue Next Year
- OBT $6.00
- ITOS $31.74
- P/E Ratio
- OBT $9.54
- ITOS N/A
- Revenue Growth
- OBT 6.48
- ITOS 177.89
- 52 Week Low
- OBT $20.97
- ITOS $4.80
- 52 Week High
- OBT $33.06
- ITOS $18.75
- Technical
- Relative Strength Index (RSI)
- OBT 52.01
- ITOS 55.62
- Support Level
- OBT $21.07
- ITOS $4.80
- Resistance Level
- OBT $22.24
- ITOS $5.55
- Average True Range (ATR)
- OBT 1.13
- ITOS 0.43
- MACD
- OBT 0.07
- ITOS 0.13
- Stochastic Oscillator
- OBT 76.19
- ITOS 97.16
About OBT Orange County Bancorp Inc.
Orange County Bancorp Inc provides banking services. Its services include personal banking services such as personal loans, personal savings, business loans, business savings, and Internet banking among others. The company provides commercial and consumer banking services to individuals, small businesses, and local municipal governments as well as trust and investment services through the Bank and HVIA. Its segment includes banking and wealth management. The company generates maximum revenue from the banking segment.
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.